[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"emergency-department-visit\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:emergency-department-visit":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,46,70,94,128,155],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100541464","an-emergency-department-ed-provider-centered-intervention-for-non-traumatic-dental-condition-management-ntdc-100541464",false,"NCT06330207","An Emergency Department (ED) Provider Centered Intervention for Non-Traumatic Dental Condition Management (NTDC)","Inclusion Criteria:\n\n* ED providers (physicians, nurse practitioners, physician assistants)\n* Working full-time in the ED\n\nExclusion Criteria:\n\n* Part-time ED providers",true,"ALL","18 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The overall objective of this proposal is to understand the barriers and facilitators to non-traumatic dental condition (NTDC) management in the emergency department (ED) through quantitative and qualitative methods. The first aim will determine the national variation in NTDC prescribing in the ED and subsequent ED\u002Furgent care revisits and hospitalizations within 30-days of an index ED visit. Using national electronic health records and integrated claims datasets and a random effects model, we will identify factors associated with prescribing for NTDC and variation at the patient, provider, hospital and state levels. The second aim identifies ED providers' perceived barriers and facilitators to the management of NTDC in the ED. Using individual in depth interviews, ED providers (physicians, advanced practice providers) will identify the facilitators and barriers to management and prescribing for NTDC in the ED.",[26,27],"Emergency Department Visit","Odontalgia",[29,30,31,32],"non-traumatic dental conditions","emergency department","opioid","antibiotic","RECRUITING","2026-05-12",{"date":36,"type":37},"2026-05-14","ACTUAL",{"date":39,"type":37},"2026-01-15",{"date":41,"type":20},"2027-08-01",{"name":43,"class":44},"University of Florida","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":45},"100579096","acute-hospital-care-at-home-for-people-living-with-dementia-100579096","NCT06819852","Acute Hospital Care at Home for People Living With Dementia","Skipping the Hospital: Acute Hospital Care at Home for People Living With Dementia","Inclusion Criteria:\n\n* Diagnosis of moderate or severe dementia (as ascertained by the Quick Dementia Rating System; QDRS)\n* Resides in a private or assisted living residence with or nearby (\\\u003C15min travel time) to a family caregiver\n* Resides within the Mass General Brigham (MGB) home hospital catchment area\n* Has had at least 1 hospitalization in the last 12 months.\n\nExclusion Criteria:\n\n* No functioning utilities, such as no working heat (October-April), no running water, or no electricity.\n* Resides in skilled nursing facility\n* Resides in group home\n* Domestic violence screen positive\n* In police custody\n* Family caregiver unable to initiate or maintain communication with care team\n* End-stage renal disease on hemodialysis\n* On methadone requiring daily pickup of medication\n* Active substance use disorder, without functioning treatment plan\n* Psychiatric diagnosis that would prohibit successful home hospital care\n* Acute delirium without explanation or without the ability to manage at home\n* Patients with cancer requiring consistent hospital-based treatments\n* Cannot ambulate to bedside commode with assistance present in the home (if different from baseline), unless home-based aides are available",{"count":54,"type":20},200,[23],"The investigators will perform a parallel-group multicenter randomized controlled trial of a 1-year pre-enrolled acute hospital care at home intervention vs usual care for people living with dementia. Patients will be randomized only after eligibility determination and after the family caregiver agrees to enroll; people living with dementia will assent when able. Patients will be allocated in a concealed fashion to the control and intervention groups in randomly selected block sizes of 4 or 6 in 4 strata reflecting their functional status (activities of daily living: 0, 1, 2-3, 4-6). Although family and clinicians cannot be blinded, the investigators will blind the data collectors and assessors.",[26,58,59],"Home Care Services","Dementia","NOT_YET_RECRUITING","2026-03-16",{"date":63,"type":37},"2026-03-17",{"date":65,"type":20},"2026-04",{"date":67,"type":20},"2028-05",{"name":69,"class":44},"Brigham and Women's Hospital",{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":80,"phases":4,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":45},"100624158","referral-of-patients-with-biological-abnormalities-to-an-emergency-department-100624158","NCT07405996","Referral of Patients With Biological Abnormalities to an Emergency Department","Referral of Patients With Biological Abnormalities to an Emergency Department : ORA","ORA","Inclusion Criteria:\n\n* Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral \"Abnormal laboratory results.\n\nExclusion Criteria:\n\n* minor patients (\\\u003C18 years old)\n* expression of the patient's opposition to the collection of data relating to their hospital stay.",{"count":79,"type":20},5000,"OBSERVATIONAL","Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.",[83,26,84],"Biological Abnormality","General Practitioner","2026-02-09",{"date":87,"type":37},"2026-02-12",{"date":89,"type":20},"2026-02-01",{"date":91,"type":20},"2027-02-01",{"name":93,"class":44},"Centre Hospitalier Régional Metz-Thionville",{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":16,"minAge":102,"maxAge":4,"enrollmentInfo":103,"targetDuration":4,"studyType":80,"phases":4,"briefSummary":105,"conditions":106,"keywords":111,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":45},"100614652","association-between-geriatric-frailty-and-medication-related-problems-in-the-emergency-department-to-help-clinical-pharmacists-prioritise-patients-100614652","NCT07282379","Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients","DETECTION OF ISAR-FLAGGED AT-RISK MEDICATION IN THE EMERGENCY DEPARTMENT (DISARMED)","DISARMED","Inclusion Criteria:\n\n* Patients aged ≥ 75 years admitted to the adult emergency department\n* Patients able to give informed consent as documented by signature or a therapeutic representative, if applicable .\n\nExclusion Criteria:\n\n* Patients initially admitted to the emergency resuscitation room.\n* Patients admitted to the minor accidents and emergencies room.\n* Patients admitted to the stroke unit, as they just pass through the emergency department to directly proceed to the CT-scanner.\n* Missing data for proper file analysis (e.g., missing usual home medication)\n* Patient's inability to sign consent and no therapeutic representative available\n* Patient's refusal to sign consent\n* Emergency physician's refusal to include patient for any reason.","75 Years",{"count":104,"type":20},300,"The healthcare systems are under increasing pressure due to a rise in emergency consultations, staff shortages, an ageing population and rising costs. Emergency departments are seeing more vulnerable patients, including elderly people, who are often on multiple medications and at risk of medication errors.\n\nTo improve safety, the integration of pharmacists specialising in emergency medicine has proven beneficial: their presence in the team improves the detection of medication-related problems, speeds up and optimises treatment, reduces rehospitalisations and lowers healthcare costs. However, in most countries, these pharmacists are still rarely found in emergency departments, mainly due to a lack of resources and clinical prioritisation criteria tailored for them and adapted to this environment.\n\nFrailty screening tools and scores, such as ISAR, can be used to identify the elderly patients most at risk, predict adverse events such as fall or mortality, and thus adapt their care in the emergency department. Indeed, elderly frail patients often take many medications and consequently are at risk of medication errors, adverse events, inappropriate prescriptions or serious drug interactions. These patients may therefore require a specialised review on their medication by clinical pharmacists when they are admitted to the emergency department, but their high number make it impossible to care for all of them.\n\nWe aim thus to evaluate the association between frailty (according to the ISAR score) and medication-related problems among elderly patients admitted to the emergency department. Researchers will examine whether this score can predict the presence of inappropriate prescribing and high-risk drug interactions. If so, pharmacists would then have a quick and easy tool to prioritise patients who would benefit most from a specialised review of their medications when they visit the emergency department.\n\nThere will not be any intervention and this study will not influence patients care. Once patients agree to participate, researchers will prospectively collect medical data from elderly patients admitted to the emergency department and analyse their medical history, home medication, reason for admission, frailty score using ISAR, and perform a pharmaceutical analysis based on these data.",[107,26,108,109,110],"Frailty","Elderly","Drug Drug Interaction","Inappropriate Drug Use",[30,112,113,114,115,116,117,118],"clinical pharmacists","elderly","frailty","ISAR","inappropriate prescription","Drug interaction","drug-related problems","2025-12-02",{"date":121,"type":37},"2025-12-15",{"date":123,"type":20},"2026-03-01",{"date":125,"type":20},"2026-09",{"name":127,"class":44},"Pharmacie des Hopitaux de l'Est Lemanique",{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":134,"eligibilityCriteria":135,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":136,"targetDuration":4,"studyType":80,"phases":4,"briefSummary":138,"conditions":139,"keywords":140,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":45},"100595843","automatic-detection-of-eligible-patients-to-rauc-protocol-raucisable-100595843","NCT07037719","Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE)","Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE): a Retrospective Monocentric Pilot Study on Big-data","RAUCISABLE","Inclusion Criteria:\n\n* Adults (age 17+), all ED patients\n\nExclusion Criteria:\n\n* Patients who object to data use",{"count":137,"type":20},300000,"The augmented rehabilitation of emergency surgeries (ARES, RAUC in French) is a research program supported by Amiens-Picardy University Hospital and the University of Picardy Jules Verne. The RAUC program aims to enhance by multiple levers (enhanced recovery programs, artificial intelligence, organizational optimization, connected devices) the management of patients operated for digestive emergency surgery. RAUCisable aims to optimize the inclusion of eligible patients in the RAUC-AMIENS study and improve predictive models for patient management.",[26],[141,142,143,144,145],"Personalized medicine","augmented rehabilitation","artificial intelligence","emergency surgery","digestive surgery","2025-06-23",{"date":148,"type":37},"2025-06-25",{"date":150,"type":37},"2025-01-17",{"date":152,"type":20},"2026-01-17",{"name":154,"class":44},"Centre Hospitalier Universitaire, Amiens",{"id":156,"slug":157,"hasResults":11,"nctId":158,"briefTitle":159,"officialTitle":160,"acronym":161,"eligibilityCriteria":162,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":163,"enrollmentInfo":164,"targetDuration":4,"studyType":21,"phases":165,"briefSummary":166,"conditions":167,"keywords":169,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":184,"completionDateStruct":186,"leadSponsor":188,"locationsCount":191},"100570183","performance-study-of-the-thermodiag-solution-for-body-temperature-measurement-100570183","NCT06703931","Performance Study of the Thermodiag Solution for Body Temperature Measurement","Evaluation of PERThermodiag® Medical Device for CT Temperature Measurement and Anomaly Detection Compared to Reference Methods in Critical Care Hospitalized Patients: a Comparative, Multi-center Interventional Study","ThermodiagPERF","Inclusion Criteria:\n\n* Patients aged 18 to 80 years;\n* Female or male patients;\n* Patients hospitalised in a critical care unit as defined by the Public Health Code of the Republic of France, Article R6123-33: 'The critical care activity consists of the care of patients who present or are likely to present one or more acute failures directly threatening the vital or functional prognosis and which may require recourse to one or more methods of substitution'.\n* Patients affiliated to the social security system or beneficiaries of such a system, where applicable, in accordance with local regulations;\n* Voluntary patients - or trusted person\u002Ffamily member\u002Frelative who have given oral and written consent after being informed by the investigator of the research.\n\nExclusion Criteria:\n\n* Patients with a corpulence or physical characteristics responsible for a 'tourniquet' effect: arm circumference greater than 47 centimetres;\n* Patients with burns on the arm (location for Thermodiag® measurement);\n* Patients with particularly sensitive or affected skin in the biceps or armpit (left and right);\n* Patients undergoing an MRI examination;\n* Patients undergoing extracorporeal circulation;\n* Patients with a history of allergy to silicone;\n* Patients with active implantable medical devices such as pacemakers, defibrillators, etc. ;\n* Patients undergoing dialysis;\n* Patients with a tattoo in the area where the investigational device will be worn (arm);\n* Patients currently excluded from another protocol or taking part in another interventional research study;\n* Pregnant or breast-feeding women.","80 Years",{"count":19,"type":20},[23],"The goal of this prospective, comparative, multi-centre interventional clinical investigation, is to evaluate the performance of the Thermodiag® medical device, compared with reference methods, for continuous measurement of core temperature in critical care patients. The main question it aims to answer is to develop non-invasive alternatives to the current methods of measuring core body, to reduce health risks, and overcome various other limitations (as infection, bleeding, thrombosis and local reactions).",[168,26],"Temperature Change, Body",[170,171,172,173,174,175,176,177,178,179,180],"Temperature","Body temperature","Monitoring temperature","multisensors","Actimetry","Actigraphy","Heart rate","Continuous measurement","Contextualized measure","Dedicated machine learning model","Machine Learning","2024-11-21",{"date":183,"type":37},"2024-11-25",{"date":185,"type":20},"2024-11-26",{"date":187,"type":20},"2025-03-30",{"name":189,"class":190},"F2D Medical","INDUSTRY",4]